These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

283 related articles for article (PubMed ID: 38347774)

  • 1. The Interplay of Comorbidities in Chronic Heart Failure: Challenges and Solutions.
    Agress S; Sheikh JS; Ramos AAP; Kashyap D; Razmjouei S; Kumar J; Singh M; Lak MA; Osman A; Zia Ul Haq M
    Curr Cardiol Rev; 2024; 20(3):13-29. PubMed ID: 38347774
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comprehensive characterization of non-cardiac comorbidities in acute heart failure: an analysis of ESC-HFA EURObservational Research Programme Heart Failure Long-Term Registry.
    Chioncel O; Benson L; Crespo-Leiro MG; Anker SD; Coats AJS; Filippatos G; McDonagh T; Margineanu C; Mebazaa A; Metra M; Piepoli MF; Adamo M; Rosano GMC; Ruschitzka F; Savarese G; Seferovic P; Volterrani M; Ferrari R; Maggioni AP; Lund LH
    Eur J Prev Cardiol; 2023 Sep; 30(13):1346-1358. PubMed ID: 37172316
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cardiac and Noncardiac Disease Burden and Treatment Effect of Sacubitril/Valsartan: Insights From a Combined PARAGON-HF and PARADIGM-HF Analysis.
    Rohde LE; Claggett BL; Wolsk E; Packer M; Zile M; Swedberg K; Rouleau J; Pfeffer MA; Desai AS; Lund LH; Kober L; Anand I; Merkely B; Senni M; Shi V; Rizkala A; Lefkowitz M; McMurray JJV; Solomon SD
    Circ Heart Fail; 2021 Mar; 14(3):e008052. PubMed ID: 33706551
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impact of comorbidities on health status measured using the Kansas City Cardiomyopathy Questionnaire in patients with heart failure with reduced and preserved ejection fraction.
    Yang M; Kondo T; Adamson C; Butt JH; Abraham WT; Desai AS; Jering KS; Køber L; Kosiborod MN; Packer M; Rouleau JL; Solomon SD; Vaduganathan M; Zile MR; Jhund PS; McMurray JJV
    Eur J Heart Fail; 2023 Sep; 25(9):1606-1618. PubMed ID: 37401511
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comorbidities in Heart Failure: Are There Gender Differences?
    Hopper I; Kotecha D; Chin KL; Mentz RJ; von Lueder TG
    Curr Heart Fail Rep; 2016 Feb; 13(1):1-12. PubMed ID: 26829930
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Non-cardiac comorbidities in heart failure with reduced, mid-range and preserved ejection fraction.
    Streng KW; Nauta JF; Hillege HL; Anker SD; Cleland JG; Dickstein K; Filippatos G; Lang CC; Metra M; Ng LL; Ponikowski P; Samani NJ; van Veldhuisen DJ; Zwinderman AH; Zannad F; Damman K; van der Meer P; Voors AA
    Int J Cardiol; 2018 Nov; 271():132-139. PubMed ID: 30482453
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Non-cardiac comorbidities in heart failure: an update on diagnostic and management strategies.
    Kodur N; Tang WHW
    Minerva Med; 2024 Jun; 115(3):337-353. PubMed ID: 38899946
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Non-cardiac comorbidities and mortality in patients with heart failure with reduced vs. preserved ejection fraction: a study using the Swedish Heart Failure Registry.
    Ergatoudes C; Schaufelberger M; Andersson B; Pivodic A; Dahlström U; Fu M
    Clin Res Cardiol; 2019 Sep; 108(9):1025-1033. PubMed ID: 30788622
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Heart failure with multiple comorbidities.
    Moe G
    Curr Opin Cardiol; 2016 Mar; 31(2):209-16. PubMed ID: 26808008
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comorbidities and differential diagnosis in heart failure with preserved ejection fraction.
    Campbell RT; McMurray JJ
    Heart Fail Clin; 2014 Jul; 10(3):481-501. PubMed ID: 24975911
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Advance in the pharmacological and comorbidities management of heart failure with preserved ejection fraction: evidence from clinical trials.
    Meifang W; Ying W; Wen C; Kaizu X; Meiyan S; Liming L
    Heart Fail Rev; 2024 Mar; 29(2):305-320. PubMed ID: 37561223
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Epidemiology of heart failure with preserved ejection fraction.
    Dhingra A; Garg A; Kaur S; Chopra S; Batra JS; Pandey A; Chaanine AH; Agarwal SK
    Curr Heart Fail Rep; 2014 Dec; 11(4):354-65. PubMed ID: 25224319
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Trends in prevalence of comorbidities in heart failure clinical trials.
    Khan MS; Samman Tahhan A; Vaduganathan M; Greene SJ; Alrohaibani A; Anker SD; Vardeny O; Fonarow GC; Butler J
    Eur J Heart Fail; 2020 Jun; 22(6):1032-1042. PubMed ID: 32293090
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comorbidities, Sociodemographic Factors, and Hospitalizations in Outpatients With Heart Failure and Preserved Ejection Fraction.
    Georgiopoulou VV; Velayati A; Burkman G; Li S; Farooq K; Samman-Tahhan A; Papadimitriou L; Butler J; Kalogeropoulos AP
    Am J Cardiol; 2018 May; 121(10):1207-1213. PubMed ID: 29525061
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Chronic heart failure].
    Hradec J
    Cas Lek Cesk; 2015; 154(6):260-8. PubMed ID: 26750621
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Particularities of Older Patients with Obstructive Sleep Apnea and Heart Failure with Mid-Range Ejection Fraction.
    Ardelean CL; Pescariu S; Lighezan DF; Pleava R; Ursoniu S; Nadasan V; Mihaicuta S
    Medicina (Kaunas); 2019 Aug; 55(8):. PubMed ID: 31394863
    [No Abstract]   [Full Text] [Related]  

  • 17. Comorbidities in Heart Failure.
    van der Wal HH; van Deursen VM; van der Meer P; Voors AA
    Handb Exp Pharmacol; 2017; 243():35-66. PubMed ID: 28382470
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sex-Based Differences in Heart Failure Across the Ejection Fraction Spectrum: Phenotyping, and Prognostic and Therapeutic Implications.
    Stolfo D; Uijl A; Vedin O; Strömberg A; Faxén UL; Rosano GMC; Sinagra G; Dahlström U; Savarese G
    JACC Heart Fail; 2019 Jun; 7(6):505-515. PubMed ID: 31146874
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Noncardiac comorbidities in heart failure with reduced versus preserved ejection fraction.
    Mentz RJ; Kelly JP; von Lueder TG; Voors AA; Lam CS; Cowie MR; Kjeldsen K; Jankowska EA; Atar D; Butler J; Fiuzat M; Zannad F; Pitt B; O'Connor CM
    J Am Coll Cardiol; 2014 Dec; 64(21):2281-93. PubMed ID: 25456761
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Reframing the association and significance of co-morbidities in heart failure.
    Triposkiadis F; Giamouzis G; Parissis J; Starling RC; Boudoulas H; Skoularigis J; Butler J; Filippatos G
    Eur J Heart Fail; 2016 Jul; 18(7):744-58. PubMed ID: 27358242
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.